课题基金 / 基金详情

CLN3 AND SUBUNIT 9 GENES AND NEURONAL SURVIVAL

CLN3 AND SUBUNIT 9 GENES AND NEURONAL SURVIVAL
CLN3 和亚基 9 基因与神经元存活
批准号:
6070005
负责人:
Rose-Mary N. BOUSTANY
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-07 至 2001-03-31

项目摘要

项目成果

Rose-Mary N. BOUSTANY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Batten's disease comprises the late infantile and juvenile types of neuronal ceroid-lipofuscinosis(LINCL and JNCL). The underlying pathophysiology of this group of diseases remains poorly understood. The determination of the responsible genetic defects at a molecular level will 1) explain heterogeneity between and within clinical subtypes; 2) revolutionize diagnostic methods by providing subtype-specific carrier and prenatal detection; 3) provide valuable insight into mechanisms of rapid neuronal cell death and the role of defective gene products in the developing nervous system. Detailed clinical and linkage studies by the investigator have established LINCL and JNCL as two distinct entities. We have shown JNCL to be linked to the haptoglobin locus. LINCL has been and will remain a poor substrate for linkage studies as the number of multiaffected families are limited due to the early demise of these patients. Fortunately, recent biochemical evidence on accumulation in the lysosome of subunit-9 of ATP synthase and dolichyl-pyrophosphate oligosaccharides that have already undergone processing implicates at least one of four genes in the pathogenesis of Batten's disease: These are the two genes coding for the precursors of subunit-9 of mitochondrial ATP synthase and the genes for microsomal glucosidase and glucosidase II. This application proposes to 1) clone the normal cDNAs for subunit-9 and study regulation of subunit-9 expression in humans by "anchored PCR" and Northern blot analysis; 2) determine the type and level of expression of subunit-9 in LINCL using the normal cDNAs as probes, detect mutations in the cDNAs for subunit-9 in LINCL by cloning and sequencing., and to confirm the occurrence of these mutations in genomic DNA from LINCL patients in single or double dose by allele-specific hybridization; 3) determine activity levels of microsomal glucosidase I and II in LINCL and JNCL by developing assay methods in human fibroblasts and lymphoblasts using colorimetric and radioactive substrates; 4) determine the effects of microsomal glucosidase I and II activity on subunit-9 accumulation in normal and Batten cell lines by Western Blot and ELISA using an affinity purified subunit-9-specific antibody. It is hoped that these studies will provide important and novel information on the etiology and pathogenesis of Batten's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLN3: Modulation of Apoptosis and Ceramide Levels
  • 批准号:
    7009590
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2003
  • 负责人:
    Rose-Mary N. BOUSTANY
  • 依托单位:
CLN3: Modulation of Apoptosis and Ceramide Levels
  • 批准号:
    6616398
  • 项目类别:
  • 资助金额:
    $36.58万
  • 财政年份:
    2003
  • 负责人:
    Rose-Mary N. BOUSTANY
  • 依托单位:
CLN3: Modulation of Apoptosis and Ceramide Levels
  • 批准号:
    6699693
  • 项目类别:
  • 资助金额:
    $36.58万
  • 财政年份:
    2003
  • 负责人:
    Rose-Mary N. BOUSTANY
  • 依托单位:
CLN3: Modulation of Apoptosis and Ceramide Levels
  • 批准号:
    6849938
  • 项目类别:
  • 资助金额:
    $36.58万
  • 财政年份:
    2003
  • 负责人:
    Rose-Mary N. BOUSTANY
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: